<SEC-DOCUMENT>0000950170-23-011796-index.html : 20230404
<SEC-HEADER>0000950170-23-011796.hdr.sgml : 20230404
<ACCEPTANCE-DATETIME>20230404165838
ACCESSION NUMBER:		0000950170-23-011796
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230404
DATE AS OF CHANGE:		20230404

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pyxis Oncology, Inc.
		CENTRAL INDEX KEY:			0001782223
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831160910
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92951
		FILM NUMBER:		23798904

	BUSINESS ADDRESS:	
		STREET 1:		35 CAMBRIDGE PARK DRIVE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140
		BUSINESS PHONE:		(617) 221-9059

	MAIL ADDRESS:	
		STREET 1:		35 CAMBRIDGE PARK DRIVE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sullivan Lara
		CENTRAL INDEX KEY:			0001769457

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	MAIL ADDRESS:	
		STREET 1:		C/O REXAHN PHARMACEUTICALS, INC.
		STREET 2:		15245 SHADY GROVE ROAD, SUITE 455
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>schedule_13da_-_lara_sul.htm
<DESCRIPTION>SC 13D/A
<TEXT>
Document 1 - file: schedule_13da_-_lara_sul.htm

</DOCUMENT>
</SEC-DOCUMENT>